Published in J Virol on August 01, 1997
Dynamics of HIV-1 recombination in its natural target cells. Proc Natl Acad Sci U S A (2004) 4.37
Viral quasispecies evolution. Microbiol Mol Biol Rev (2012) 2.69
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spots. J Virol (2002) 2.50
High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication. J Virol (2003) 2.04
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
Antiretroviral drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase increase template-switching frequency. J Virol (2004) 1.59
Human immunodeficiency virus type 1 genetic recombination is more frequent than that of Moloney murine leukemia virus despite similar template switching rates. J Virol (2003) 1.52
Turnover of env variable region 1 and 2 genotypes in subjects with late-stage human immunodeficiency virus type 1 infection. J Virol (2003) 1.44
Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching. Proc Natl Acad Sci U S A (2001) 1.44
Altering the intracellular environment increases the frequency of tandem repeat deletion during Moloney murine leukemia virus reverse transcription. J Virol (1999) 1.42
Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol (2000) 1.38
Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J Virol (1998) 1.34
Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. J Virol (1999) 1.23
Correlated template-switching events during minus-strand DNA synthesis: a mechanism for high negative interference during retroviral recombination. J Virol (1998) 1.21
Effects of varying sequence similarity on the frequency of repeat deletion during reverse transcription of a human immunodeficiency virus type 1 vector. J Virol (2002) 1.16
Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary. J Virol (2001) 1.14
Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J Virol (1998) 1.12
Nonrandom dimerization of murine leukemia virus genomic RNAs. J Virol (2004) 1.11
High rate of genetic recombination in murine leukemia virus: implications for influencing proviral ploidy. J Virol (2006) 1.08
Evidence for preferential copackaging of Moloney murine leukemia virus genomic RNAs transcribed in the same chromosomal site. Retrovirology (2005) 1.06
RNase H activity is required for high-frequency repeat deletion during Moloney murine leukemia virus replication. J Virol (2002) 1.05
Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Res (2006) 1.02
Mechanisms and factors that influence high frequency retroviral recombination. Viruses (2011) 1.02
Recombination in the 5' leader of murine leukemia virus is accurate and influenced by sequence identity with a strong bias toward the kissing-loop dimerization region. J Virol (1998) 1.01
Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo. J Virol (2000) 0.96
Two distinct Moloney murine leukemia virus RNAs produced from a single locus dimerize at random. Virology (2005) 0.95
High frequency of genetic recombination is a common feature of primate lentivirus replication. J Virol (2006) 0.94
Effect of the murine leukemia virus extended packaging signal on the rates and locations of retroviral recombination. J Virol (2000) 0.93
Accurately measuring recombination between closely related HIV-1 genomes. PLoS Comput Biol (2010) 0.90
Mechanisms of human immunodeficiency virus type 2 RNA packaging: efficient trans packaging and selection of RNA copackaging partners. J Virol (2011) 0.83
Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors. J Virol (1998) 0.82
Genetic analysis of the rat leukemia virus: influence of viral sequences in transduction of the c-ras proto-oncogene and expression of its transforming activity. J Virol (1998) 0.81
Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription. J Virol (1999) 0.80
Recombination can lead to spurious results in retroviral transduction with dually fluorescent reporter genes. J Virol (2013) 0.78
Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene. Hum Gene Ther Methods (2016) 0.76
Retroviral vectors for analysis of viral mutagenesis and recombination. Viruses (2014) 0.76
Quantitative analysis of recombination between YFP and CFP genes of FRET biosensors introduced by lentiviral or retroviral gene transfer. Sci Rep (2015) 0.76
Cross- and Co-Packaging of Retroviral RNAs and Their Consequences. Viruses (2016) 0.75
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
A restriction enzyme cleavage map of Tn5 and location of a region encoding neomycin resistance. Mol Gen Genet (1979) 19.37
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science (1995) 18.40
High Negative Interference over Short Segments of the Genetic Structure of Bacteriophage T4. Genetics (1958) 10.85
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J Virol (1995) 9.02
A detailed model of reverse transcription and tests of crucial aspects. Cell (1979) 8.93
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol (1979) 7.69
Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci U S A (1990) 6.66
Retroviral recombination and reverse transcription. Science (1990) 6.27
The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat Med (1996) 5.46
Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptase. Science (1996) 5.08
Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Mol Cell Biol (1983) 4.96
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: substitutions, frameshifts, and hypermutations. Proc Natl Acad Sci U S A (1990) 4.72
On the molecular basis of high negative interference. Proc Natl Acad Sci U S A (1974) 4.25
Retrovirus variation and reverse transcription: abnormal strand transfers result in retrovirus genetic variation. Proc Natl Acad Sci U S A (1993) 4.04
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Genetic recombination of human immunodeficiency virus. J Virol (1989) 3.61
How does HIV cause AIDS? Science (1993) 2.92
Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication. J Virol (1988) 2.88
New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors. J Virol (1989) 2.86
Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science (1993) 2.64
Generation of diversity in retroviruses. Annu Rev Genet (1990) 2.53
Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors. Virology (1984) 2.38
Homologous recombination of copackaged retrovirus RNAs during reverse transcription. J Virol (1992) 2.29
Retroviral recombination during reverse transcription. Proc Natl Acad Sci U S A (1990) 2.17
High-frequency deletion between homologous sequences during retrotransposition of Ty elements in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1987) 2.12
mRNA and cytoskeletal filaments. Curr Opin Cell Biol (1997) 2.11
Sex and recombination in retroviruses. Trends Genet (1991) 2.08
Involvement of directly repeated sequences in the generation of deletions of the avian sarcoma virus src gene. J Virol (1983) 1.94
Retroviral recombination can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance. J Virol (1995) 1.80
Instability of large direct repeats in retrovirus vectors. J Virol (1987) 1.78
Lower mutation rate of bovine leukemia virus relative to that of spleen necrosis virus. J Virol (1994) 1.76
Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J Virol (1995) 1.62
One retroviral RNA is sufficient for synthesis of viral DNA. J Virol (1994) 1.60
Present status and future prospects for HIV therapies. Science (1993) 1.52
Effect of gamma radiation on retroviral recombination. J Virol (1992) 1.43
Immunofluorescent studies of RD-114 virus replication in cell culture. J Gen Virol (1974) 1.43
Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors. J Virol (1997) 1.40
E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J Virol (1995) 1.32
Scientific and social issues of human immunodeficiency virus vaccine development. Science (1993) 1.22
High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector. J Virol (1993) 1.21
Alteration of location of dimer linkage sequence in retroviral RNA: little effect on replication or homologous recombination. J Virol (1993) 1.21
Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J Virol (1996) 1.14
cis-acting signals and trans-acting proteins are involved in tau mRNA targeting into neurites of differentiating neuronal cells. Int J Dev Neurosci (1995) 1.14
Transforming variants of the avian myc-containing retrovirus FH3 arise prior to phenotypic selection. J Virol (1993) 0.87
Exogenous tau RNA is localized in oocytes: possible evidence for evolutionary conservation of localization mechanisms. Dev Biol (1996) 0.80
The phosphorylation state of eucaryotic initiation factor 2 alters translational efficiency of specific mRNAs. Mol Cell Biol (1989) 4.81
Dynamic copy choice: steady state between murine leukemia virus polymerase and polymerase-dependent RNase H activity determines frequency of in vivo template switching. Proc Natl Acad Sci U S A (2001) 1.44
Psi- vectors: murine leukemia virus-based self-inactivating and self-activating retroviral vectors. J Virol (1997) 1.40
Deoxyribonucleoside triphosphate pool imbalances in vivo are associated with an increased retroviral mutation rate. J Virol (1998) 1.40
Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching. J Virol (2000) 1.38
Retroviral recombination rates do not increase linearly with marker distance and are limited by the size of the recombining subpopulation. J Virol (1998) 1.34
E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy. J Virol (1995) 1.32
Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching. J Virol (1999) 1.23
The antiretrovirus drug 3'-azido-3'-deoxythymidine increases the retrovirus mutation rate. J Virol (1997) 1.16
Retroviral mutation rates and A-to-G hypermutations during different stages of retroviral replication. J Virol (1996) 1.14
Relative rates of retroviral reverse transcriptase template switching during RNA- and DNA-dependent DNA synthesis. J Virol (1998) 1.12
Design of retroviral vectors and helper cells for gene therapy. Pharmacol Rev (2000) 1.02
Utilization of nonhomologous minus-strand DNA transfer to generate recombinant retroviruses. J Virol (1997) 0.99
Development of an in vivo assay to identify structural determinants in murine leukemia virus reverse transcriptase important for fidelity. J Virol (2000) 0.97
Utilization of nonviral sequences for minus-strand DNA transfer and gene reconstitution during retroviral replication. J Virol (2000) 0.97
Wild-type and YMDD mutant murine leukemia virus reverse transcriptases are resistant to 2',3'-dideoxy-3'-thiacytidine. J Virol (2000) 0.97
Effect of the murine leukemia virus extended packaging signal on the rates and locations of retroviral recombination. J Virol (2000) 0.93
Role of murine leukemia virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in retroviral replication and in vivo fidelity. J Virol (2000) 0.87
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples. Adv Virol (2011) 0.87
Efficient initiation and strand transfer of polypurine tract-primed plus-strand DNA prevent strand transfer of internally initiated plus-strand DNA. J Virol (1996) 0.87
Development of murine leukemia virus-based self-activating vectors that efficiently delete the selectable drug resistance gene during reverse transcription. J Virol (1999) 0.80
Sensitive radiochemical assay for inosine 5'-monophosphate dehydrogenase and determination of activity in murine tumor and tissue extracts. Cancer Res (1983) 0.79
Survey of int region DNA rearrangements in C3H and BALB/cfC3H mouse mammary tumor system. J Natl Cancer Inst (1987) 0.78
Involvement of thyroid gland in the development of migratory disposition in the redheaded bunting, Emberiza bruniceps. Horm Behav (1982) 0.76
Restricted food intake and annual thyroid cycle of spotted munia. Gen Comp Endocrinol (1980) 0.75
Iopanoic acid prevents spring premigratory increase in body weight of redheaded bunting Emberiza bruniceps. Indian J Exp Biol (1989) 0.75
Immune status with empyema thoracis. Indian J Pediatr (2004) 0.75
Seasonal variations in extrathyroidal conversion of thyroxine to tri-iodothyronine and migratory disposition in redheaded bunting. Gen Comp Endocrinol (1982) 0.75
Treatment of alcoholism in the subacute stage. (A study of three active agents). Dis Nerv Syst (1966) 0.75
Seasonal variations in circulating thyroxine and triiodothyronine concentrations in spotted munia Lonchura punctulata. Gen Comp Endocrinol (1983) 0.75
Information systems for the value management era. Healthc Financ Manage (1986) 0.75
Effect of corticosteroids on carbohydrate metabolism in Bufo melanostictus (Schneider). Indian J Exp Biol (1989) 0.75
Epidermoid carcinoma and pathological fracture developing in a case of chronic osteomyelitis. J Indian Med Assoc (1984) 0.75
Managing information systems: still a CFO function. Healthc Financ Manage (1986) 0.75
Variations in circulating thyroxine and triiodothyronine concentration in relation to spring migration in rosy pastor, Sturnus roseus. Horm Behav (1984) 0.75